Aquaporin-2-Guided Tolvaptan Therapy in Patients With Congestive Heart Failure Accompanied by Chronic Kidney Disease

被引：11
作者：
Imamura, Teruhiko [1 ]
机构：
[1] Univ Tokyo, Dept Therapeut Strategy Heart Failure, Grad Sch Med, Tokyo 1138655, Japan
来源：
INTERNATIONAL HEART JOURNAL | 2014年 / 55卷 / 06期
关键词：
VASOPRESSIN RECEPTOR ANTAGONIST; WATER CHANNEL; EXCRETION; CLONING; VOLUME; RAT;
D O I：
10.1536/ihj.14-217
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：482 / 483
页数：2
相关论文
共 13 条
[1]   CLONING AND EXPRESSION OF APICAL MEMBRANE WATER CHANNEL OF RAT-KIDNEY COLLECTING TUBULE [J].
FUSHIMI, K ;
UCHIDA, S ;
HARA, Y ;
HIRATA, Y ;
MARUMO, F ;
SASAKI, S .
NATURE, 1993, 361 (6412) :549-552
[2]  
Imamura T, CIRC J IN PRESS
[3]   Assessment of Quality of Life During Long-Term Treatment of Tolvaptan in Refractory Heart Failure Design and Rationale of the AQUA-TLV Study [J].
Imamura, Teruhiko ;
Kinugawa, Koichiro ;
Ohtani, Tomohito ;
Sakata, Yasushi ;
Higo, Taiki ;
Kinugawa, Shintaro ;
Tsutsui, Hiroyuki ;
Sunagawa, Kenji ;
Komuro, Issei .
INTERNATIONAL HEART JOURNAL, 2014, 55 (03) :264-267
[4]   Urine Sodium Excretion After Tolvaptan Administration Is Dependent Upon Baseline Serum Sodium Levels A Possible Explanation for the Improvement of Hyponatremia With Scarce Chance of Hypernatremia by a Vasopressin Receptor Antagonist [J].
Imamura, Teruhiko ;
Kinugawa, Koichiro ;
Minatsuki, Shun ;
Muraoka, Hironori ;
Kato, Naoko ;
Inaba, Toshiro ;
Maki, Hisataka ;
Hatano, Masaru ;
Yao, Atsushi ;
Komuro, Issei .
INTERNATIONAL HEART JOURNAL, 2014, 55 (02) :131-137
[5]   Tolvaptan Can Improve Clinical Course in Responders Validation Analysis for the Definition of Responsiveness by Urine Volume [J].
Imamura, Teruhiko ;
Kinugawa, Koichiro ;
Minatsuki, Shun ;
Muraoka, Hironori ;
Kato, Naoko ;
Inaba, Toshiro ;
Maki, Hisataka ;
Hatano, Masaru ;
Yao, Atsushi ;
Komuro, Issei .
INTERNATIONAL HEART JOURNAL, 2013, 54 (06) :377-381
[6]   Novel Criteria of Urine Osmolality Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients - Association Between Non-Responders and Chronic Kidney Disease [J].
Imamura, Teruhiko ;
Kinugawa, Koichiro ;
Shiga, Taro ;
Kato, Naoko ;
Muraoka, Hironori ;
Minatsuki, Shun ;
Inaba, Toshiro ;
Maki, Hisataka ;
Hatano, Masaru ;
Yao, Atsushi ;
Kyo, Shunei ;
Nagai, Ryozo .
CIRCULATION JOURNAL, 2013, 77 (02) :397-404
[7]   Experience of a Vasopressin Receptor Antagonist, Tolvaptan, Under the Unique Indication in Japanese Heart Failure Patients [J].
Kinugawa, K. ;
Imamura, T. ;
Komuro, I. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (04) :449-451
[8]   Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload - An Interim Result of Post-Marketing Surveillance in Japan [J].
Kinugawa, Koichiro ;
Sato, Naoki ;
Inomata, Takayuki ;
Shimakawa, Toshiyuki ;
Iwatake, Noriaki ;
Mizuguchi, Kazuki .
CIRCULATION JOURNAL, 2014, 78 (04) :844-852
[9]   Effects of oral tolvaptan in patients hospitalized for worsening heart failure - The EVEREST outcome trial [J].
Konstam, Marvin A. ;
Gheorghiade, Mihai ;
Burnett, John C., Jr. ;
Grinfeld, Liliana ;
Maggioni, Aldo P. ;
Swedberg, Karl ;
Udelson, James E. ;
Zannad, Faiez ;
Cook, Thomas ;
Ouyang, John ;
Zimmer, Christopher ;
Orlandi, Cesare .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (12) :1319-1331
[10]   Aquaporin-2 regulation in health and disease [J].
Radin, M. Judith ;
Yu, Ming-Jiun ;
Stoedkilde, Lene ;
Miller, R. Lance ;
Hoffert, Jason D. ;
Frokiaer, Jorgen ;
Pisitkun, Trairak ;
Knepper, Mark A. .
VETERINARY CLINICAL PATHOLOGY, 2012, 41 (04) :455-470
12